Privacy Watchdog Brings Healthcare Company into Compliance with Ad Privacy Best Practices
703.247.9330 / firstname.lastname@example.org
McLean, VA – December 1, 2020 – BBB National Programs’ data privacy watchdog, the Digital Advertising Accountability Program (DAAP), today released the result of a new data privacy case for the healthcare and medical devices company Abbott. Abbott worked with DAAP to bring more than 60 of its websites into compliance with the Digital Advertising Alliance’s (DAA) Self-Regulatory Principles.
DAAP monitors the digital marketplace and receives consumer complaints about online privacy, interest-based advertising (IBA), and compliance with the DAA Principles. In response to a consumer complaint about possible privacy issues on an Abbott website featuring cardiovascular products, DAAP conducted a full review of the company’s websites. Finding that there were signs of data collection on several of Abbott’s sites without the enhanced notice of background data collection required by the DAA Principles, DAAP contacted the company about its privacy practices.
Abbott quickly responded to DAAP’s inquiry and worked to reach compliance with the DAA Principles. The company:
- Added an enhanced notice link labeled “Advertising Preferences” to each of its websites that leads to a disclosure about targeted advertising and a consumer opt-out tool
- Audited its mobile apps and decommissioned an app where third-party data collection for IBA was taking place
- Added a statement of adherence to the DAA Principles to its privacy policies
“Enhanced notice of third parties collecting data on a website for interest-based advertising is critically important in the medical context,” said Jon Brescia, Vice President, DAAP. “We thank Abbott for the great efforts it took to prioritize end-user privacy, especially during this unique time of heightened consumer interest in health-related information and products.”
DAAP has published 124 public actions since the program began its self-regulatory mission in 2011. Of those, 11 have been published in 2020.
About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.
About the Digital Advertising Accountability Program: The Digital Advertising Accountability Program (DAAP), a division of BBB National Programs, was developed by the Digital Advertising Alliance (DAA) to enforce industry self-regulation principles for data privacy in online and mobile advertising, holding companies accountable to the DAA’s Privacy Principles. DAAP provides guidance to companies looking to comply with industry principles and responds to complaints filed by consumers about online privacy.
Children’s Advertising Review Unit Determines that Visual Supply Company App Is Not “Directed Primarily or Secondarily to Children”
DSSRC Refers Health-Related Product and Earnings Claims for Gano Excel to FTC
McLean, VA – January 13, 2021 – The Direct Selling Self-Regulatory Council (DSSRC) referred certain product performance and income claims made by Gano Excel USA to the Federal Trade Commission (FTC) for possible enforcement action after Gano Excel failed to provide substantiation for the claims.
NARB Refers Health-Related Claims for Theraworx Relief for Muscle and Joint Products to the FTC
New York, NY – January 12, 2021 – A panel of the National Advertising Review Board (NARB) has referred advertising claims made by Avadim Health, Inc. to the Federal Trade Commission (FTC) for review and possible enforcement action. The referral comes after the company declined to comply with a NARB recommendation to discontinue...
NAD Recommends Zarbee’s Inc. Qualify Use of the Term “Natural” in its Brand-Name for Some of its Dietary Supplement Products, and Modify Additional Claims
New York, NY – January 7, 2021 – The National Advertising Division (NAD) recommended that Zarbee’s qualify its use of the term “natural” in the Zarbee’s Naturals brand name when some or all the essential or key ingredients used in its products are...